We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Transapical Access Device Facilitates Structural Heart Disease Procedures

By HospiMedica International staff writers
Posted on 17 Aug 2016
Print article
Image: The Permaseal device (Photo courtesy of Micro Interventional Devices).
Image: The Permaseal device (Photo courtesy of Micro Interventional Devices).
A novel transapical access and closure device helps enter the left ventricular cavity for delivery of interventional instruments.

The Permaseal device is designed to allow surgeons to access and close the left ventricle reliably, and without suturing the myocardium, in a range of minimally invasive cardiac procedures, including transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR), and patent foramen ovale (PFO). The device employs PolyCor anchoring technology, which simultaneously deploys eight anchors, all connected together by a suture, into the heart tissue at high velocities, slicing open an access hole.

Once the procedure has been completed and the access hole needs to be sealed, the threaded suture loop is pulled upon, and the anchors are drawn together, like a purse string. In a clinical study to validate the device, Permaseal shortened operating time and hospital stay, reduced adverse events (including transfusion needs), and reduced 12-month mortality and stroke rates to zero. The Permaseal device and PolyCor anchoring technology are products of Micro Interventional Devices (MID; Newtown, PA, USA), and have been approved by the U.S. Food and Drug Administration (FDA).

“Permaseal is the first in a series of products designed to replace the need for suturing in structural heart procedures. We are excited that this technology is now available to our U.S. and European surgeons and their patients,” said Michael Whitman, President and CEO of MID. “In the near future, PolyCor and MyoLast technologies will be utilized in a broad range of proprietary, catheter-based products addressing unmet needs in tricuspid repair, mitral repair, and mitral valve fixation. MID's technology platform enables open-surgical procedures to be performed percutaneously.”

Heart muscle is friable, and tends to tear along natural cleavage planes. As a result, if a slit is made in the myocardium, it begins to tear away from the edge of the incision. The transapical approach is used to safely access the interior of the heart by using a coring device to create a round access port. After the procedure, the tissues are pulled together and sewn, holding the apex together until it heals and fills with scar tissue.

Related Links:
Micro Interventional Devices

Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Wireless Handheld Ultrasound System
TE Air

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.